HKMPY

$45.36-$0.86 (-1.86%)live

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$31.80 – $50.56

72% from low

Exchange

OTC Link

ADRC

Change$-14.90

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$3.5B	+4.0%	$0.00	$0.00–$0.00	—	0
2027	$3.6B	+4.4%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Intrinsic value

$62.42

Price

$45.35

Implied upside

+38%

Symbol	Price	Today	Mkt cap	P/E
HKMPYHikma Pharmaceuticals PLC	$45.35	-1.86%	$4.7B	—
DNPUFSumitomo Pharma Co., Ltd.	$8.41	+0.00%	$3.8B	—
GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited	$2.34	+0.00%	$6.2B	—
HLBBFH. Lundbeck A/S	$6.05	+0.00%	$4.8B	—
HLUBFH. Lundbeck A/S	$5.54	+2.08%	$5.9B	—
LVZPFLivzon Pharmaceutical Group Inc.	$5.22	+0.00%	$6.1B

Source: Financial Modeling Prep · peers by sector/industry

No one on the platform currently holds HKMPY.

Institutions holding (13F)

No tracked institution reports a position in HKMPY as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

TTM yield · 7.50% ($3.40/share)

No one on the platform has traded HKMPY yet.